Phototherapy Devices Market Size, Share, Growth, and Industry Analysis, By Type (Conventional Phototherapy Devices, Fiber Optic Phototherapy Devices, Others), By Application (Hospitals, Dermatology Clinics, Home Care), Regional Insights and Forecast to 2035

Phototherapy Devices Market Overview

The global Phototherapy Devices Market size estimated at USD 603.02 million in 2026 and is projected to reach USD 771.92 million by 2035, growing at a CAGR of 2.78% from 2026 to 2035.

The phototherapy devices market focuses on advanced medical equipment that uses controlled light therapy for treating neonatal jaundice, dermatological disorders, and seasonal conditions. In 2024, more than 3 million newborns globally required phototherapy treatment annually due to elevated bilirubin levels. Phototherapy devices use LED, fluorescent, and fiber optic technologies to deliver therapeutic wavelengths between 400 nm and 550 nm. The neonatal segment represents a major demand area because approximately 60% of newborn jaundice cases require monitoring or treatment support. Rising healthcare infrastructure development, increasing premature birth rates, and technological advancements in portable phototherapy devices are strengthening market adoption.

The United States phototherapy devices market is supported by advanced neonatal care infrastructure and increasing demand for dermatology treatment solutions. In 2024, the country recorded approximately 3.6 million births, with neonatal jaundice affecting nearly 60% of newborns at different severity levels. Hospitals account for more than 70% of phototherapy device usage in the USA due to advanced neonatal intensive care units. LED-based phototherapy systems represent approximately 80% of newly installed devices because of improved energy efficiency and longer operational life. Dermatology clinics also contribute significantly, with more than 10,000 specialized clinics using light-based treatment technologies for psoriasis, vitiligo, and eczema management.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Increasing neonatal care demand contributes approximately 65% growth influence, while rising premature births account for nearly 15%, supporting continuous adoption of advanced phototherapy devices in hospitals and healthcare centers.
• Major Market Restraint: High equipment costs influence approximately 35% of purchasing challenges, while maintenance requirements contribute nearly 25%, limiting adoption in smaller healthcare facilities and developing regions.
• Emerging Trends: LED technology represents nearly 80% of new device development, while portable phototherapy systems account for approximately 40% adoption growth interest among home healthcare providers.
• Regional Leadership: North America contributes approximately 35% market share, Europe accounts for nearly 30%, while Asia-Pacific represents around **25% due to increasing healthcare infrastructure investments.
• Competitive Landscape: Top manufacturers collectively control approximately 45% of the market, with leading companies focusing on LED innovation, portable systems, and digital monitoring technologies.
• Market Segmentation: Hospital applications represent nearly 60% demand share, while dermatology clinics contribute approximately 25%, supported by increasing treatment requirements for skin disorders.
• Recent Development: Approximately 70% of recent product launches between 2023 and 2025 included improved LED systems, smart controls, and enhanced patient monitoring features.

Phototherapy Devices Market Latest Trends

The phototherapy devices market is experiencing significant technological transformation due to increasing demand for efficient, patient-friendly, and cost-effective treatment solutions. In 2024, LED-based phototherapy devices represented approximately 80% of newly developed neonatal systems because LED technology provides consistent wavelength output, reduced heat generation, and longer device lifespan compared with traditional fluorescent systems. Hospitals are increasingly adopting portable phototherapy units, with mobile systems accounting for nearly 30% of new installations in neonatal care facilities. Smart phototherapy devices equipped with digital monitoring features are becoming more common. Approximately 50% of advanced models launched after 2023 included temperature monitoring, treatment tracking, and remote data management capabilities. These technologies improve clinical decision-making by allowing healthcare providers to monitor therapy duration and patient response.

Dermatology applications are expanding rapidly as phototherapy devices become more compact and user-friendly. Narrowband UVB technology, operating around 311 nm wavelength, remains one of the most widely used approaches for psoriasis and vitiligo treatment. Dermatology clinics account for nearly 25% of phototherapy device demand, driven by increasing awareness of non-invasive skin treatments. Home-use phototherapy devices are also gaining acceptance, with approximately 20% of consumers seeking portable solutions for chronic skin conditions. Manufacturers are focusing on lightweight designs, rechargeable battery systems, and automated exposure controls to improve patient convenience.

Phototherapy Devices Market Dynamics

The phototherapy devices market is influenced by healthcare modernization, rising neonatal healthcare requirements, increasing dermatological disease prevalence, and continuous product innovation. Approximately 15 million premature births occur globally each year, creating substantial demand for neonatal phototherapy equipment. Hospitals continue to represent the largest end-user segment, accounting for nearly 60% of total device utilization.

Technological advancement remains a key factor shaping market dynamics. LED phototherapy systems have replaced many conventional systems because they consume approximately 50% less energy and provide longer operational performance. Manufacturers are investing in compact, portable, and digitally connected devices to meet changing healthcare requirements. The growing prevalence of skin disorders is another important market factor. Conditions such as psoriasis affect approximately 2% to 3% of the global population, while vitiligo impacts nearly 1% of individuals worldwide, increasing demand for dermatology phototherapy solutions. Healthcare facilities in emerging economies are expanding neonatal intensive care capacity, creating additional opportunities for phototherapy device adoption. Approximately 70% of hospitals in developed markets have access to advanced neonatal phototherapy systems, while developing regions continue upgrading medical infrastructure.

DRIVER

"Rising demand for neonatal care and advanced LED phototherapy systems."

The increasing number of premature births and neonatal complications is the primary factor driving the phototherapy devices market. Approximately 15 million premature babies are born annually worldwide, and neonatal jaundice affects nearly 60% of newborns, creating continuous demand for effective treatment solutions. Hospitals are replacing older fluorescent phototherapy equipment with LED-based systems because LED devices provide improved efficiency, lower heat emission, and longer operating life. In 2024, LED phototherapy systems represented approximately 80% of newly installed neonatal phototherapy equipment. Growing investments in neonatal intensive care units, particularly in emerging economies, are increasing the requirement for reliable phototherapy devices. Healthcare providers are also adopting portable systems because they allow flexible treatment options in smaller medical facilities.

RESTRAINT

"High equipment costs and limited accessibility in developing healthcare markets."

The high initial investment associated with advanced phototherapy devices remains a significant market limitation. Approximately 35% of smaller hospitals and clinics identify equipment affordability as a major adoption barrier. Advanced LED phototherapy systems require specialized components, regular maintenance, and trained healthcare professionals, increasing operational costs. In developing countries, limited healthcare budgets restrict the purchase of premium phototherapy equipment despite growing neonatal care requirements. Approximately 25% of healthcare facilities in low-resource regions continue using older phototherapy technologies due to cost considerations. Maintenance expenses, replacement of light sources, and calibration requirements further influence purchasing decisions. Manufacturers are addressing this challenge by developing affordable portable devices and simplified treatment systems for emerging markets.

OPPORTUNITY

"Expansion of portable and home-based phototherapy solutions."

The increasing demand for decentralized healthcare creates significant opportunities for portable phototherapy devices. Approximately 20% of patients with chronic dermatological conditions prefer home-based treatment solutions, encouraging manufacturers to develop compact and easy-to-use systems. Advances in battery technology, miniaturized LED modules, and wireless monitoring are improving the usability of home phototherapy devices. Emerging economies represent additional growth opportunities because healthcare infrastructure expansion is increasing access to neonatal treatment. More than 50% of new healthcare facilities constructed in developing regions include neonatal care capabilities, creating demand for phototherapy equipment. Digital health integration is another opportunity, with approximately 40% of new medical device designs incorporating connectivity features for remote monitoring and treatment management.

CHALLENGE

"Regulatory requirements and technological complexity in phototherapy device development."

Phototherapy device manufacturers face challenges related to strict regulatory approval processes, product safety requirements, and continuous technological advancement. Approximately 70% of medical device manufacturers identify regulatory compliance as a major development challenge. Phototherapy systems must maintain accurate wavelength delivery, patient safety standards, and consistent treatment performance. The integration of smart monitoring technologies increases product complexity and requires additional testing before commercialization. Competition among manufacturers also creates pressure to introduce innovative products while maintaining affordability. Approximately 45% of companies in the medical device sector are investing in digital healthcare technologies, increasing competition within the phototherapy devices market. Ensuring device reliability, reducing production costs, and meeting regional healthcare regulations remain key challenges for industry participants.

Phototherapy Devices Market Segmentation

Download FREE Sample to learn more about this report.

The phototherapy devices market is segmented based on type and application, with technology selection depending on treatment requirements, healthcare infrastructure, and patient needs. By type, conventional phototherapy devices, fiber optic phototherapy devices, and advanced systems represent major categories. In 2024, conventional phototherapy devices accounted for approximately 55% market usage due to their widespread presence in hospitals, while fiber optic systems contributed nearly 30% because of improved portability. By application, hospitals remained the largest segment with approximately 60% adoption, followed by dermatology clinics at around 25% and home care applications at nearly 15%. Increasing neonatal care demand and rising skin disorder prevalence continue influencing segmentation patterns.

BY TYPE

Conventional Phototherapy Devices: Conventional phototherapy devices represent the largest segment of the phototherapy devices market, accounting for approximately 55% market share in 2024. These systems are widely used in hospitals and neonatal intensive care units because of their established clinical effectiveness and availability. Conventional devices generally use fluorescent lamps or LED panels positioned above infant incubators or treatment beds to deliver therapeutic light. More than 70% of hospitals globally continue operating conventional phototherapy systems because of their reliability and simple operational design. The demand for conventional phototherapy devices remains strong in emerging markets where healthcare facilities require cost-effective treatment solutions. Approximately 50% of hospitals in developing regions prefer conventional systems due to lower acquisition costs compared with advanced portable alternatives. Manufacturers are improving conventional models by integrating LED technology, adjustable intensity controls, and improved safety mechanisms.

Fiber Optic Phototherapy Devices: Fiber optic phototherapy devices account for approximately 30% of the phototherapy devices market and are gaining popularity because of their flexibility, portability, and improved patient comfort. These systems use fiber optic blankets or pads that deliver light directly to the infant’s skin, allowing treatment while maintaining greater mobility. Approximately 40% of neonatal care centers adopting advanced phototherapy technologies prefer fiber optic systems because they enable easier handling and reduce disruption during treatment. Fiber optic devices are particularly beneficial for premature infants requiring extended therapy periods because they allow easier feeding and parental interaction.

Others: Other phototherapy devices include specialized systems designed for dermatological treatments, combination therapies, and advanced clinical applications. This category represents approximately 15% market share in 2024 and includes targeted UV phototherapy equipment, handheld systems, and specialized treatment units. Dermatology clinics are the primary users of these devices, accounting for nearly 70% of demand within this segment. Increasing prevalence of psoriasis, eczema, and vitiligo is supporting adoption of specialized phototherapy solutions. Narrowband UVB systems operating around 311 nm wavelength remain widely used for chronic skin disorder treatment.

BY APPLICATION

Hospitals: Hospitals represent the largest application segment of the phototherapy devices market, accounting for approximately 60% market share in 2024. Neonatal intensive care units are the primary users because newborn jaundice remains one of the most common conditions requiring phototherapy treatment. Approximately 60% of newborns develop some level of jaundice, creating continuous demand for hospital-based phototherapy equipment. Large hospitals typically operate multiple phototherapy units to support neonatal care departments. More than 70% of tertiary hospitals worldwide have dedicated neonatal phototherapy systems. The increasing number of premature births, estimated at approximately 15 million annually, continues driving hospital demand.

Dermatology Clinics: Dermatology clinics account for approximately 25% of the phototherapy devices market, supported by increasing demand for non-invasive skin treatments. Phototherapy is commonly used for psoriasis, vitiligo, eczema, and other inflammatory skin conditions. Psoriasis affects approximately 2% to 3% of the global population, while vitiligo impacts nearly 1% of people worldwide, creating a significant patient base requiring long-term treatment. Dermatology clinics increasingly invest in narrowband UVB and targeted phototherapy devices. Approximately 50% of dermatology clinics offering advanced light-based treatments use narrowband UVB technology due to its effectiveness and established clinical acceptance. Portable and compact devices are becoming popular because clinics require efficient treatment solutions with reduced space requirements.

Home Care: Home care applications represent approximately 15% of the phototherapy devices market and are expanding due to increasing patient preference for convenient treatment options. Home-based phototherapy allows patients with chronic skin disorders to receive regular treatment without frequent hospital visits. Home care phototherapy demand is also increasing in regions with limited access to specialized healthcare facilities. Approximately 40% of rural healthcare users benefit from portable medical technologies, creating opportunities for affordable phototherapy solutions.

Phototherapy Devices Market Regional Outlook

Download FREE Sample to learn more about this report.

The phototherapy devices market shows strong regional growth due to increasing neonatal healthcare demand, rising dermatological disease prevalence, and healthcare infrastructure development. North America leads with approximately 35% market share, supported by advanced hospitals and high adoption of LED technologies. Europe accounts for nearly 30%, driven by established healthcare systems and dermatology treatment demand. Asia-Pacific contributes approximately 25%, supported by increasing birth rates and healthcare investments. Middle East & Africa represents around 10%, with growth influenced by improving medical infrastructure and increasing awareness of phototherapy treatment options.

NORTH AMERICA

North America represents the leading region in the phototherapy devices market, accounting for approximately 35% market share in 2024 due to advanced healthcare infrastructure, high neonatal care availability, and strong adoption of innovative medical technologies. The United States contributes the majority of regional demand, supported by more than 5,000 hospitals providing neonatal and specialized healthcare services. Approximately 70% of advanced hospitals in North America operate dedicated neonatal intensive care units, creating consistent demand for phototherapy devices. The increasing number of premature births is a major factor supporting regional growth. The United States records approximately 370,000 premature births annually, increasing the requirement for neonatal phototherapy systems. LED-based phototherapy devices dominate new installations, representing nearly 80% of recently purchased systems because of their improved efficiency, reduced heat output, and longer operating life.  Home-use phototherapy devices are also gaining acceptance, particularly among dermatology patients requiring continuous treatment. Around 20% of chronic skin disorder patients prefer home-based therapy options, encouraging product development in compact LED and UV systems. Government healthcare investments, increasing awareness, and advanced clinical adoption continue supporting North America's position in the phototherapy devices market.

EUROPE

Europe represents one of the largest markets for phototherapy devices, contributing approximately 30% market share in 2024 due to strong healthcare systems, advanced neonatal care facilities, and increasing demand for dermatological treatment technologies. Countries including Germany, France, the United Kingdom, Italy, and Spain are major contributors to regional adoption. Neonatal phototherapy remains the largest application area in Europe because newborn jaundice affects approximately 60% of infants globally, creating significant treatment requirements. European hospitals increasingly prefer LED phototherapy systems, with LED technology representing nearly 75% of newly installed neonatal devices due to lower energy consumption and improved treatment efficiency. Germany maintains a strong position in the European phototherapy devices market due to its advanced healthcare infrastructure and large hospital network. Approximately 80% of German tertiary hospitals provide specialized neonatal care services, supporting consistent equipment demand. France and the United Kingdom also contribute significantly due to government-supported healthcare modernization programs. Home-based phototherapy adoption is also increasing in European countries with strong healthcare accessibility. Approximately 15% of phototherapy treatments are performed outside hospitals, supported by portable and user-friendly devices. Increasing healthcare expenditure, aging populations, and technological innovation continue strengthening Europe's role in the phototherapy devices market.

ASIA-PACIFIC

Asia-Pacific represents a rapidly expanding region in the phototherapy devices market, accounting for approximately 25% market share in 2024 due to rising birth rates, improving healthcare infrastructure, and increasing awareness of advanced treatment technologies. China, Japan, India, South Korea, and Australia are major contributors to regional demand. China represents the largest market in Asia-Pacific because of its large population base and expanding healthcare system. The country records approximately 9 million births annually, creating significant demand for neonatal phototherapy devices. Hospitals in major Chinese cities are increasingly adopting LED systems, with LED technology accounting for nearly 70% of newly installed phototherapy equipment. India is another important growth market due to increasing healthcare investments and a large number of annual births. India records approximately 25 million births each year, creating substantial demand for neonatal care equipment. More than 60% of newborn care facilities in urban hospitals use phototherapy systems for jaundice management. Manufacturers in Asia-Pacific are focusing on affordable phototherapy solutions to meet regional healthcare requirements. Approximately 50% of new product developments in the region focus on cost-efficient designs. Government healthcare expansion programs, increasing hospital construction, and growing medical technology adoption continue supporting Asia-Pacific growth in the phototherapy devices market.

MIDDLE EAST & AFRICA

The Middle East & Africa phototherapy devices market represents an emerging regional segment, accounting for approximately 10% market share in 2024. Growth is supported by improving healthcare infrastructure, increasing neonatal care investments, and rising awareness of dermatological treatment options. Middle Eastern countries including Saudi Arabia, United Arab Emirates, and Qatar are leading regional adoption due to advanced hospitals and increasing healthcare modernization. Approximately 70% of major hospitals in Gulf countries operate neonatal intensive care units, creating demand for phototherapy devices. LED-based systems represent nearly 75% of newly purchased equipment because of improved energy efficiency. The region experiences significant demand for neonatal phototherapy because newborn jaundice remains common. Approximately 50% to 60% of newborns experience jaundice symptoms, requiring monitoring and treatment support. Hospitals represent the largest application segment, accounting for nearly 70% of regional phototherapy device demand. Portable phototherapy systems are gaining importance in areas with limited healthcare accessibility. Around 30% of manufacturers are developing compact systems targeted toward emerging markets. Increased healthcare funding, medical equipment modernization, and partnerships for improving newborn care services are expected to support the Middle East & Africa phototherapy devices market.

List of Top Phototherapy Devices Market Companies

• Natus
• GE Healthcare
• Draeger
• Medela
• Daavlin
• National Biological
• Nice Neotech Medical Systems
• Guangzhou Beautylife Electronic Technology
• Heal Force Bio-Meditech Holdings Limited

List of Top 2 Companies Market Share

• Natus: Natus holds a leading position in the phototherapy devices market with approximately 15% global market share, supported by strong neonatal care product offerings and widespread adoption of advanced infant care technologies. The company focuses on LED phototherapy systems, monitoring solutions, and hospital-based neonatal equipment.
• GE Healthcare: GE Healthcare accounts for approximately 12% market share in the phototherapy devices market due to its extensive healthcare technology portfolio and presence across hospitals worldwide. The company emphasizes advanced neonatal care systems, digital monitoring, and integrated healthcare solutions.

Investment Analysis and Opportunities

The phototherapy devices market provides attractive investment opportunities due to increasing demand for neonatal care technologies, dermatology treatment solutions, and portable healthcare equipment. Approximately 15 million premature births occur annually worldwide, creating continuous demand for neonatal phototherapy systems. Investors are focusing on LED technology, digital healthcare integration, and portable device manufacturing. Investment opportunities are increasing in emerging economies where healthcare infrastructure is expanding. Approximately 50% of new healthcare facilities in developing regions require neonatal treatment equipment, creating opportunities for manufacturers offering affordable phototherapy solutions.

Digital transformation is becoming a key investment area. Around 40% of new phototherapy devices introduced after 2023 included smart monitoring features, allowing healthcare professionals to track treatment performance and patient response. Dermatology applications provide additional opportunities because approximately 2% to 3% of the global population experiences psoriasis, while vitiligo affects nearly 1% of people worldwide. Rising demand for non-invasive treatments is encouraging investment in targeted phototherapy systems. Manufacturers are also investing in home-care solutions. Approximately 20% of patients with chronic skin conditions prefer home treatment options, increasing demand for portable LED and UV devices. Research and development activities are focusing on compact designs, improved safety features, and connected healthcare capabilities.

New Product Development

Phototherapy device manufacturers are increasingly focusing on innovation to improve treatment efficiency, patient comfort, and digital connectivity. In 2024, approximately 70% of newly launched phototherapy devices included LED-based technology due to improved energy efficiency and longer operational performance. Portable phototherapy systems are becoming a major product development focus. Manufacturers are introducing lightweight devices with rechargeable batteries and automated exposure controls. Approximately 30% of new product designs after 2023 focused on portability and home-care applications.

Smart phototherapy systems equipped with wireless monitoring and digital data management features are expanding. Nearly 40% of advanced phototherapy devices now include connectivity features that allow healthcare professionals to monitor treatment sessions remotely.

Dermatology-focused product development is increasing due to growing demand for targeted skin treatments. Manufacturers are developing narrowband UVB devices with improved wavelength accuracy around 311 nm, supporting treatment for psoriasis and vitiligo. Artificial intelligence integration is another emerging innovation area. Approximately 25% of new medical device prototypes include AI-based monitoring capabilities for automated treatment adjustment and improved patient safety.  Manufacturers are also developing energy-efficient systems that reduce operating costs. Around 50% of recent innovations focus on improving LED efficiency, reducing heat generation, and extending device lifespan.

Five Recent Developments  

• In 2023, Natus introduced improved neonatal phototherapy solutions featuring advanced LED technology and enhanced treatment monitoring capabilities.
• In 2023, GE Healthcare expanded neonatal care equipment offerings with upgraded phototherapy systems designed for hospital environments.
• In 2024, Daavlin launched advanced dermatology phototherapy solutions with improved UV light control and patient monitoring features.
• In 2024, Nice Neotech Medical Systems introduced upgraded neonatal phototherapy devices focusing on energy efficiency and compact designs.
• In 2025, Heal Force Bio-Meditech expanded portable phototherapy product development with lightweight systems designed for home healthcare applications.

Report Coverage of Phototherapy Devices Market

The phototherapy devices market report covers comprehensive analysis based on product type, application, regional performance, competitive landscape, investment trends, and technological developments. The study evaluates conventional phototherapy devices, fiber optic phototherapy devices, and other specialized systems. The report analyzes major applications including hospitals, dermatology clinics, and home care. Hospitals represent approximately 60% of total demand, while dermatology clinics contribute nearly 25% due to increasing adoption of light-based skin treatments.

Regional analysis includes North America, Europe, Asia-Pacific, and Middle East & Africa. North America contributes approximately 35% market share, Europe accounts for nearly 30%, Asia-Pacific represents around 25%, and Middle East & Africa contributes approximately 10%. The competitive assessment includes major companies such as Natus, GE Healthcare, Draeger, Medela, and Daavlin. More than 9 key manufacturers participate actively in the global phototherapy devices market.